Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation.

PubWeight™: 1.79‹?› | Rank: Top 3%

🔗 View Article (PMID 12784234)

Published in Head Neck on June 01, 2003

Authors

Jeri A Logemann1, Barbara Roa Pauloski, Alfred W Rademaker, Cathy L Lazarus, Bharat Mittal, Joy Gaziano, Linda Stachowiak, Ellen MacCracken, Lisa A Newman

Author Affiliations

1: Northwestern University, Department of Communication Sciences and Disorders, 2299 N Campus Drive, Evanston, Illinois 60208, USA. j-logemann@northwestern.edu

Articles citing this

Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol (2010) 2.41

Salivary diagnostics: enhancing disease detection and making medicine better. Eur J Dent Educ (2008) 1.44

Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck (2006) 1.40

A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer. Support Care Cancer (2009) 1.15

Swallowing dysfunction in cancer patients. Support Care Cancer (2011) 1.12

Dysphagia in head and neck cancer patients treated with chemoradiotherapy. Dysphagia (2009) 1.04

Rehabilitation of dysphagia following head and neck cancer. Phys Med Rehabil Clin N Am (2008) 1.00

Physiological changes to the swallowing mechanism following (chemo)radiotherapy for head and neck cancer: a systematic review. Dysphagia (2013) 1.00

Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia. Support Care Cancer (2007) 0.99

Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol (2009) 0.99

Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer. Strahlenther Onkol (2011) 0.92

Validity of patient-reported swallowing and speech outcomes in relation to objectively measured oral function among patients treated for oral or oropharyngeal cancer. Dysphagia (2015) 0.89

Pressure topography metrics for high-resolution pharyngeal-esophageal manofluorography-a normative study of younger and older adults. Neurogastroenterol Motil (2016) 0.88

Changes in swallowing physiology and patient perception of swallowing function following chemoradiation for head and neck cancer. Dysphagia (2014) 0.85

Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer. Head Neck (2014) 0.83

Effects of reduced saliva production on swallowing in patients with Sjogren's syndrome. Dysphagia (2010) 0.81

A survey of variables used by speech-language pathologists to assess function and predict functional recovery in oral cancer patients. Dysphagia (2014) 0.81

Dry mouth and dietary quality in older adults in north Carolina. J Am Geriatr Soc (2011) 0.81

Study protocol for a randomized controlled trial: tongue strengthening exercises in head and neck cancer patients, does exercise load matter? Trials (2015) 0.80

Relation of mucous membrane alterations to oral intake during the first year after treatment for head and neck cancer. Head Neck (2010) 0.79

Efficacy of thickened liquids for eliminating aspiration in head and neck cancer: a systematic review. Otolaryngol Head Neck Surg (2014) 0.79

A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia (2011) 0.78

Systematic review of dose--volume correlates for structures related to late swallowing disturbances after radiotherapy for head and neck cancer. Dysphagia (2013) 0.77

The relationships between xerostomia and dysphagia after chemoradiation of head and neck cancer. Head Neck (2003) 0.77

Oral cancer malnutrition impacts weight and quality of life. Nutrients (2015) 0.77

How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study. Acta Otorhinolaryngol Ital (2016) 0.76

Radioprotective effects of pyrroloquinoline quinone on parotid glands in C57BL/6J mice. Exp Ther Med (2016) 0.75

Effects of Change in Tongue Pressure and Salivary Flow Rate on Swallow Efficiency Following Chemoradiation Treatment for Head and Neck Cancer. Dysphagia (2016) 0.75

Quality of life in patients with dysphagia after radiation and chemotherapy treatment for head and neck tumors. J Clin Exp Dent (2013) 0.75

Articles by these authors

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2014) 4.61

Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer (2006) 2.79

Oropharyngeal deglutition in stable COPD. Chest (2002) 2.79

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood (2013) 2.65

Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol (2002) 2.51

Behavioral intervention to promote smoking cessation and prevent weight gain: a systematic review and meta-analysis. Addiction (2009) 2.46

American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J Clin Oncol (2011) 2.30

Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol (2008) 2.14

Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol (2005) 2.10

Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer (2005) 2.05

Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: a call for dialogue. Genet Med (2009) 1.98

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol (2009) 1.90

Perceptions of clinical research participation among African American women. J Womens Health (Larchmt) (2007) 1.86

Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol (2006) 1.75

A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015. Cancer (2006) 1.73

Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer (2002) 1.69

Effects of voluntary maneuvers on tongue base function for swallowing. Folia Phoniatr Logop (2002) 1.64

Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations. Cancer (2011) 1.59

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol (2003) 1.52

Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic mice. J Natl Cancer Inst (2002) 1.50

Oropharyngeal swallow in younger and older women: videofluoroscopic analysis. J Speech Lang Hear Res (2002) 1.49

Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia. Leuk Res (2011) 1.44

Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol (2008) 1.42

Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancer. Cancer Invest (2002) 1.40

Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck (2006) 1.40

Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg (2005) 1.39

Colorectal cancer screening among African-American and white male veterans. Am J Prev Med (2005) 1.39

Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome. Diabetes Care (2007) 1.37

Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 1.37

A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas. Cancer (2010) 1.35

The effects of taste and consistency on swallow physiology in younger and older healthy individuals: a surface electromyographic study. J Speech Lang Hear Res (2003) 1.35

Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck (2002) 1.34

Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma. J Clin Oncol (2004) 1.31

Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. J Clin Oncol (2002) 1.31

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat (2005) 1.30

Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology (2004) 1.29

Surface electromyographic and electroglottographic studies in normal subjects under two swallow conditions: normal and during the Mendelsohn manuever. Dysphagia (2002) 1.29

Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma. J Clin Oncol (2009) 1.28

High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab (2009) 1.26

Swallowing disorders in the first year after radiation and chemoradiation. Head Neck (2008) 1.25

A randomized study comparing the Shaker exercise with traditional therapy: a preliminary study. Dysphagia (2009) 1.23

Results of the Lynn Sage Second-Opinion Program for local therapy in patients with breast carcinoma. Changes in management and determinants of where care is delivered. Cancer (2002) 1.22

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol (2007) 1.21

Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys (2010) 1.21

Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. Cancer Res (2003) 1.19

The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer (2004) 1.18

Effects of two types of tongue strengthening exercises in young normals. Folia Phoniatr Logop (2003) 1.17

Management of patients with locally advanced breast cancer. Surg Clin North Am (2007) 1.17

Surgical variables affecting swallowing in patients treated for oral/oropharyngeal cancer. Head Neck (2004) 1.16

Swallowing and dysphagia rehabilitation: translating principles of neural plasticity into clinically oriented evidence. J Speech Lang Hear Res (2008) 1.15

Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J (2009) 1.14

Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline. J Clin Oncol (2014) 1.13

Assessing breast cancer risk: evolution of the Gail Model. J Natl Cancer Inst (2006) 1.13

A midpoint assessment of the American Cancer Society challenge goal to decrease cancer incidence by 25% between 1992 and 2015. CA Cancer J Clin (2007) 1.12

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood (2005) 1.12

Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol (2008) 1.12

Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. Head Neck (2006) 1.11

Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram? Ann Surg Oncol (2005) 1.11

Breast cancer risk assessment models: applicability to African-American women. Cancer (2003) 1.09

Peripheral excision margins for dermatofibrosarcoma protuberans: a meta-analysis of spatial data. Ann Surg Oncol (2007) 1.08

Residual disease after re-excision lumpectomy for close margins. J Surg Oncol (2009) 1.08

Complications in breast surgery. Surg Clin North Am (2007) 1.07

Oral and oropharyngeal perceptions of fluid viscosity across the age span. Dysphagia (2006) 1.07

Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. Head Neck (2007) 1.05

Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin North Am (2007) 1.04

Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol (2007) 1.04

Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women. Cancer (2012) 1.03

Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg (2002) 1.03

Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J Clin Endocrinol Metab (2002) 1.03

Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol (2002) 1.02

Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol (2011) 1.02

Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck (2002) 1.02

Relationship between manometric and videofluoroscopic measures of swallow function in healthy adults and patients treated for head and neck cancer with various modalities. Dysphagia (2008) 1.01

Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer (2003) 1.00

A comparison of the frequency of sperm chromosome abnormalities in men with mild, moderate, and severe oligozoospermia. Biol Reprod (2003) 0.99

Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing breast cancer surgery. Am J Surg (2011) 0.99

Pregnancy-associated breast cancer: a literature review. Surg Clin North Am (2007) 0.99

FOBT completion in FQHCs: impact of physician recommendation, FOBT information, or receipt of the FOBT kit. J Rural Health (2012) 0.98

Maternal obesity and vitamin D sufficiency are associated with cord blood vitamin D insufficiency. J Clin Endocrinol Metab (2012) 0.98